Portfolio company
Tivic Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops immunotherapeutic drugs and biomanufacturing services for patients with radiation injury, cancer and age-related immune dysfunction.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Thymmune
This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.
Eradivir
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
Tcubeit
This company develops T cell manufacturing platforms and immunotherapy pipelines for pharmaceutical firms and research institutions treating cancer and rare diseases.
Deciduous Therapeutics
This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.
immunique
This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.
Silverback Therapeutics
This biopharmaceutical company develops immune-modulating therapeutics for patients with cancer and chronic viral infections.
Nuvig
Nuvig Therapeutics develops immunomodulatory medicines to treat patients with chronic inflammatory and autoimmune diseases.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
